First-Line Medication for Paranoia of Unknown Etiology
Start with a second-generation antipsychotic at low doses—specifically risperidone 2 mg/day or olanzapine 7.5-10 mg/day—as these are the recommended initial treatments for psychotic symptoms including paranoia. 1, 2
Initial Approach
When paranoia presents without a clear diagnosis, treat it as first-episode psychosis until proven otherwise. The most recent international guidelines emphasize early intervention with antipsychotics when psychotic symptoms (including paranoia) have been present for a week or more with associated distress or functional impairment 1.
Key Medication Choices
For first-line treatment:
- Risperidone 2 mg/day 2
- Olanzapine 7.5-10 mg/day (consider with metformin to prevent weight gain) 1, 2
- Amisulpride or paliperidone are also appropriate first-line options 1
The choice should be made collaboratively with the patient based on side-effect profiles, with particular attention to avoiding extrapyramidal symptoms that reduce future adherence 2.
Treatment Algorithm
Step 1: Initial 4-Week Trial
Give the chosen antipsychotic at therapeutic dose for at least 4 weeks assuming good adherence 1. Do not increase doses prematurely—wait 14-21 days between adjustments after initial titration 2.
Step 2: If Inadequate Response After 4 Weeks
Switch to an alternative antipsychotic with a different pharmacodynamic profile 1. If you started with a D2 partial agonist (like aripiprazole), switch to amisulpride, risperidone, paliperidone, or olanzapine 1.
Step 3: If Second Antipsychotic Fails After 4 Weeks
- Reassess the diagnosis
- Rule out organic illness and substance use
- If schizophrenia spectrum disorder is confirmed, initiate clozapine 1
- Start metformin concurrently with clozapine 1
Important Caveats
Before starting any antipsychotic:
- Rule out substance-induced psychosis (consider delaying treatment if symptoms are clearly substance-related and no safety concerns exist) 1
- Exclude medical conditions causing psychosis 2
- Assess for delirium or other acute medical issues
Avoid benzodiazepines for paranoia—they carry significant long-term risks without addressing the underlying psychotic process 3.
Special Considerations for Delusional Disorder
If the paranoia manifests as isolated delusions without other psychotic features, pimozide has historically shown the best results for delusional disorder specifically 4. However, the 2025 guidelines prioritize the broader second-generation antipsychotics listed above for initial treatment 1. Aripiprazole (average effective dose 11.1 mg/day) may be effective for delusional disorders with good tolerability, though evidence is limited to case reports 5.
Dosing Principles
- Use the lowest effective dose 1
- Avoid high doses that increase extrapyramidal side-effects, as these destroy adherence 2
- Maximum initial doses should not exceed 4-6 mg haloperidol equivalent in first-episode presentations 2
- Address side-effects promptly 1
The distinction between first-generation and second-generation antipsychotics should not guide your choice—focus instead on specific receptor profiles and side-effect considerations 1.